William Kwabena Ampofo is Associate Professor and Head of the Virology Department, Noguchi Memorial Institute for Medical Research (NMIMR), College of Health Sciences, University of Ghana, Legon, Accra, Ghana.
Tolu Disu is a senior healthcare professional with near 15 years-experience in biopharma, healthcare consulting, public health and med tech sectors in technical, commercial and management roles.
Dr Simon Agwale has a Ph.D. in virology and vaccinology. He has over 20 years’ experience combining top-level scientific research with the operations of Biotech companies.
Patrick Tippoo has more than 30 years experience in the vaccine manufacturing industry. He has been with Biovac, a private public partnership in South Africa, since its inception in 2003.
Jean-Vivien Mombouli is molecular and cellular pharmacologist with à PhD from Université de Poitiers (France) in 1985.
Dr. Chidi Nweneka was recently re-elected as a board member of AVMI during the 2021 virtual annual general meeting.
Anissa Boumlic-Courtade, is Director, Head of the Strategy operationalization group within Bioprocessing Strategy, Process Solutions division of Life Sciences division of Merck kgAa, Darmstadt Germany.
Tarisayi Matongo is a qualified bioprocess engineer (MSC, UCT) by training.
Dr Rajesh Sharma is working as a Scientist in Antigen production team at The Biovac Institute.
Melissa Schouw is currently the Executive and Administrative Assistant at AVMI.
Matthew Williams currently serves as a downstream scientist in the Science & Innovation department at Biovac,
Kerisha Batohi is the team lead at Cape Biologix Technologies, a transient plant-based expression production facility based in Cape Town.
Ebrahim Mohamed is a Synthetic Organic Chemist by training with over 15 years’ experience in pharmaceuticals with expertise covering business development, product development, technology transfers, process optimizations and cGMP.
Daria Kow is currently employed at Biovac within the Science & Innovation department as a Group Leader, where she oversees the quality aspects of the development vaccines.
Charlie is a Scientist/Attorney with passion for Intellectual Property (“IP”) and the implementation of the associated rights particularly for start-up companies.
Akhona Gura is currently the Purification Scientist at Biovac.